| 证券代码：300791 | 证券简称：仙乐健康 | 公告编码：2026-004 | | --- | --- | --- | | 债券代码：123113 | 债券简称：仙乐转债 | | 仙乐健康科技股份有限公司 关于筹划发行 H 股股票并在香港联合交易所有限公司 上市的提示性公告 共和国证券法》（以下简称"《证券法》"）、《境内企业境外发行证券和上市 管理试行办法》（以下简称"《境外上市管理办法》"）、《监管规则适用指引 ——境外发行上市类第 1 号》等有关法律、法规和监管规则的规定，结合公司自 身实际情况，公司本次 H 股上市符合境内有关法律、行政法规、部门规章和规 范性文件的要求和条件。 根据《香港联合交易所有限公司证券上市规则》（以下简称"《香港上市规 则》"）以及香港法律对在中国境内注册成立的发行人在香港发行股票并上市的 有关规定，公司本次 H 股上市将在符合香港法律及《香港上市规则》的要求和 条件下进行，并根据需要取得中国证券监督管理委员会（以下简称"中国证监 会"）、香港联交所和香港证券及期货事务监察委员会（以下简称"香港证监会"） 等相关政府机构、监管机构的备案、审核或批准。 相关具体内容详见 ...

3、经公司第四届董事会第十七次会议审议并通过了《关于提请召开 2026 年第一次临时股东会的议案》。本次会议的召集、召开符合《中华人民共和国公 司法》《深圳证券交易所创业板股票上市规则》《深圳证券交易所上市公司自律监 管指引第 2 号—创业板上市公司规范运作》等法律、行政法规、部门规章、规范 性文件及《公司章程》的有关规定。 4、会议时间： | 证券代码：300791 | 证券简称：仙乐健康 | 公告编码：2026-010 | | --- | --- | --- | | 债券代码：123113 | 债券简称：仙乐转债 | | 仙乐健康科技股份有限公司 关于召开 2026 年第一次临时股东会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 仙乐健康科技股份有限公司（以下简称"公司"、"本公司"）定于 2026 年 1 月 27 日（星期二）召开 2026 年第一次临时股东会，现将会议有关事项通知 如下： 一、召开会议的基本情况 1、股东会届次：2026 年第一次临时股东会 2、股东会的召集人：董事会 （1）现场会议时间：2026 年 01 月 27 日 1 ...

| 证券代码：300791 | 证券简称：仙乐健康 | 公告编码：2026-003 | | --- | --- | --- | | 债券代码：123113 | 债券简称：仙乐转债 | | 仙乐健康科技股份有限公司 第四届董事会第十七次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、 董事会会议召开情况 仙乐健康科技股份有限公司（以下简称"公司"）第四届董事会第十七次会 议于 2026 年 1 月 8 日在上海市长宁来福士 33 楼公司会议室以现场会议与通讯表 决相结合的方式召开。会议通知于 2026 年 1 月 5 日以电子邮件、微信信息等方 式送达给全体董事及其他列席人员。本次会议由董事长林培青先生召集和主持， 应出席董事 8 人，实际出席董事 8 人，其中董事朱桂龙以通讯方式出席。公司高 级管理人员及独立董事候选人列席本次会议。本次会议的召集、召开符合《中华 人民共和国公司法》《中华人民共和国证券法》《深圳证券交易所创业板股票上 市规则》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规 范运作》《仙乐健康科技股份有限公司 ...

Core Viewpoint - The company plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance its global strategy and capital strength [1] Group 1 - The fourth meeting of the fourth board of directors is scheduled for January 8, 2026, to review the proposal for issuing H-shares [1] - The initiative aims to leverage international capital market advantages to improve the company's capital strength and overall competitiveness [1] - The company is currently in discussions with relevant intermediaries regarding the issuance and listing details, which are not yet finalized [1]

Market Strategy - The market is experiencing fluctuations, with the Shanghai Composite Index slightly rising, achieving a fourteen-day consecutive increase [7] - The overall A-share market saw a 0.19% increase, closing at 6654.1 points, while the Shanghai Composite Index rose by 0.05% to 4085.77 points [7] - The hard technology sector is performing well, with the Sci-Tech 50 Index increasing by 0.99% [7] Industry Dynamics - In 2025, the number of new A-share accounts reached 27.44 million, a 10% increase compared to 2024 [27] - The market for on-site food production in supermarkets in China has surpassed 100 billion yuan, with major supermarket chains achieving a sales share of 10%-20% [29] - A subsidiary of China Communications Construction Company, along with CRRC and MTR, secured over 7 billion Australian dollars in contracts for the Sydney Metro project [31][33] Company Tracking - GF Securities plans to raise capital for its overseas subsidiary through a combination of private placement and convertible bonds, aiming to raise approximately 6.11 billion Hong Kong dollars [34] - Xianle Health obtained 9 invention patents and 2 health food registration certificates in Q4 2025, enhancing its product pipeline [36] - Qianjin Pharmaceutical received drug registration certificates for several products, which will contribute to the company's sustainable development [38]

Group 1: Overall Market Trends - In the first three quarters of 2025, China's VC/PE investment reached 8,295 cases, a year-on-year increase of 19.8%, with total investment amounting to 540.73 billion yuan, up 9.0% from 2024 [1] - The sports investment market in China saw 35 financing events in 2025, totaling approximately 1.6754 billion yuan, which is an increase of about 18.42% in the number of events and approximately 40% in total investment compared to the previous year [5] - The overall investment landscape in 2025 indicates a recovery, although it remains at a low level compared to previous years [5] Group 2: Sector-Specific Insights - The outdoor sports sector continues to gain traction, with 10 financing events in this area, accounting for 27.78% of total events and totaling 819.8 million yuan, which is 48.93% of the total investment [8] - The AI and sports sector is emerging as a significant focus, with 10 financing events totaling 340 million yuan, representing 20.29% of the total investment [12] - The esports sector remains relatively quiet, with a total financing amount of approximately 326 million yuan, accounting for 19.46% of the total [15] Group 3: Notable Companies and Investments - PELLIOT secured 300 million yuan in strategic investment from Tencent, marking a significant move in the outdoor sports brand sector [9] - The AI sports imaging brand Photon Leap completed a multi-hundred million yuan angel round financing, setting a record for angel round financing in the consumer imaging field [13] - The outdoor brand SURPINE completed a Pre-A round financing of several million yuan, supported by the Jie Bai Consumer Fund, to enhance its offline presence [10] Group 4: IPO Movements - Outdoor brands like PELLIOT and Tanboer have submitted IPO applications to the Hong Kong Stock Exchange, indicating a push towards capital market entry [23] - The sports shoe manufacturer Longxing Tianxia has initiated the IPO process on the Shanghai Stock Exchange, targeting overseas capacity expansion and production line upgrades [23]

Core Viewpoint - Xianle Health announced the acquisition of 9 invention patents and 2 health food registration certificates in Q4 2025, indicating a focus on innovation and product development [2]. Group 1: Patent Acquisitions - The company and its subsidiaries obtained 9 invention patents, which include 4 patents from China, 2 from Europe, 2 from Canada, and 1 from Australia [2]. - The acquisition of these patents reflects the company's commitment to expanding its intellectual property portfolio and enhancing its competitive edge in the health sector [2]. Group 2: Health Food Registration - Xianle Health secured 2 health food registration certificates, although there were no new health food registration certificates issued [2]. - This indicates ongoing compliance with regulatory requirements in the health food sector, which is crucial for market access and consumer trust [2].

| 证券代码：300791 | 证券简称：仙乐健康 | 公告编码：2026-002 | | --- | --- | --- | | 债券代码：123113 | 债券简称：仙乐转债 | | 仙乐健康科技股份有限公司 | 序号 | 专利名称 | 专利号 | 类别 | 取得 | 取得时间 | 专利权人 | 有效期限 | | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | 方式 | | | 至 | | 1 | 一种含脂溶性维生素的组合物 | ZL202311631443.6 | 发明 | 原始取得 | 2025-10-24 | 安徽仙乐 | 2043-12-01 | | 2 | Soft capsule shells and soft capsules | CA3167605 | 发明 | 原始取得 | 2025-11-18 | 仙乐健康 | 2041-12-28 | | 3 | Oleogel and preparation method therefor and use thereof | AU2023217798 | 发明 | 原始取得 | 2 ...

| 证券代码：300791 | 证券简称：仙乐健康 | 公告编码：2026-001 | | --- | --- | --- | | 债券代码：123113 | 债券简称：仙乐转债 | | 仙乐健康科技股份有限公司 关于 2025 年第四季度可转债转股情况的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 特别提示： （一）可转换公司债券发行概况 经中国证券监督管理委员会《关于同意仙乐健康科技股份有限公司向不特定 对象发行可转换公司债券注册的批复》（证监许可〔2021〕927 号）同意注册， 仙乐健康科技股份有限公司（以下简称"仙乐健康"或"公司"）向不特定对象 发行可转换公司债券 1,024.89 万张，每张面值 100.00 元，募集资金总额为人民 币 102,489.29 万元，扣除相关发行费用后实际募集资金净额为人民币 101,616.75 万元。本次向不特定对象发行的可转换公司债券向公司在股权登记日收市后登记 在册的原股东优先配售，原股东优先配售后余额部分（含原股东放弃优先配售部 分）通过深圳证券交易所（以下简称"深交所"）交易系统网上向社会公众投 ...

Core Viewpoint - Different consumer sectors exhibit both differences and commonalities in recovery rhythms, with ROA being a leading indicator for operational recovery in consumer enterprises [1][2] Group 1: Recovery Rhythm Analysis - The recovery rhythm of various consumer sectors is influenced by industry supply and demand, as well as supply chain structures, with a focus on stock market competition as a mainstream phenomenon [2] - The stages of enterprise and channel adjustments are outlined, starting from oversupply to a new balance in supply and demand, with ROA serving as a key indicator throughout these stages [2] - Current recovery sequences indicate that soft drinks and snacks are leading, followed by food supply chains, condiments, dairy products, beer, and finally, liquor [2][3] Group 2: Investment Strategy - Emphasis on sectors where ROA stabilizes, indicating potential valuation recovery opportunities, with a preference for sectors that still show price or volume growth [3] - Price logic suggests that rising CPI may drive valuation recovery in traditional industries with high penetration rates, such as liquor, beer, and dairy products, which are likely to attract incremental capital [3][4] - Recommended companies in the liquor sector include Kweichow Moutai, Luzhou Laojiao, and Shanxi Fenjiu, while in dairy, focus on Yili and Mengniu [3] Group 3: Volume Logic - In the context of cost-effective consumption, companies with high supply chain efficiency are expected to gain volume, with specific recommendations for companies in the food supply chain and soft drinks [4] - Industries with low penetration rates may withstand economic cycles, with recommendations for low-alcohol beverages and functional foods that can enhance brand premium through specialization [4] - Companies benefiting from overseas market expansion include Angel Yeast and Bailong Chuangyuan [4]